Alcoholism

The Medical Basis of Psychiatry: Third Edition

Volumn , Issue , 2008, Pages 227-249

  Garbutt, James C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acamprosate; Alcohol abuse; Alcohol dependence; Brief intervention; Diagnosis; Genetics; Naltrexone; Treatment

Indexed keywords

EID: 84856407771     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-252-6_14     Document Type: Chapter

References (155)

1. Ewing JA, Rouse BA, eds. Drinking. Alcohol in American Society-Issues and Current Research. Chicago: Nelson-Hall, 1978.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
3. Jellinek EM. The Disease Concept of Alcoholism. New Haven: Hillhouse Press, 1960.
4. National Center for Health Statistics, Health, United States, 2005.
5. Wechsler H, Lee JE, Kuo M, Lee H. College binge drinking in the 1990s: a continuing problem. Results of the Harvard School of Public Health 1999 College Alcohol Study. J Am Coll Health 2000;48(5):199-210.
6. Naimi TS, Brewer RD, Mokdad A, Denny C, Serdula MK, Marks JS. Binge drinking among US adults. JAMA 2003;289(1):70-75.
7. Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend 2004;74(3):223-234.
8. Hasin DS, Grant BF. The co-occurrence of DSM-IV alcohol abuse in DSM-IV alcohol dependence: results of the National Epidemiologic Survey on Alcohol and Related Conditions on heterogeneity that differ by population subgroup. Arch Gen Psychiatry 2004;61(9):891-896.
9. Rehm J, Sempos CT, Trevisan M. Alcohol and cardiovascular disease-more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease-a review. J Cardiovasc Risk 2003;10(1): 15-20.
10. Rehm J, Gmel G, Sempos CT, Trevisan M. Alcohol-related morbidity and mortality. Alcohol Res Health 2003;27(1): 39-51.
11. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004;38(5):613-619.
12. Randall CL, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME. Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol 1999;60(2):252-260.
13. Hingson R, Howland J. Alcohol as a risk factor for injuries or death resulting from accidental falls: A review of the literature. J Stud Alcohol 1987;48:212-219.
14. Howland J, Hingson R. Alcohol as a risk factor for injuries or death due to fires and burns: Review of the literature. Public Health Rep 1987;102:475-483.
15. Howland J, Hingson R. Issues in research on alcohol in nonvehicular unintentional injuries. Contemp Drug Probl 1988;(Spring):95-106.
16. Sullivan EV, Pfefferbaum A. Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology (Berl) 2005;180(4):583-594.
17. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemio-logic Catchment Area (ECA) Study. JAMA 1990;264(19): 2511-2518.
18. Brown SA, Schuckit MA. Changes in depression among abstinent alcoholics. J Stud Alcohol 1988;49(5):412-417.
19. Brower KJ. Insomnia, alcoholism and relapse. Sleep Med Rev 2003;7(6):523-539.
20. Landolt HP, Gillin JC. Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. CNS Drugs 2001;15(5):413-425.
21. Drummond SP, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 1998;22(8): 1796-1802.
22. Breese GR, Overstreet DH, Knapp DJ. Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology (Berl) 2005;178(4):367-380.
23. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: What is the relationship? Am J Psychiatry 1994;151(12):1723-1734.
24. Sher L. Risk and protective factors for suicide in patients with alcoholism. Sci World J 2006;6:1405-1411.
25. Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA 2003;290(22):2996-2999.
26. CDC. Alcohol consumption among pregnant and childbearing-aged women-United States 1991-1999. MMWR 2000;51(13):273-276.
27. Goodwin DW. Alcoholism. In: Goodwin DW, Guze SB, eds. Psychiatric Diagnosis. New York: Oxford University Press, 1984: 147-178.
28. Holt S, Skinner HA, Israel Y. Early identification of alcohol abuse: 11. Clinical and laboratory indicators. Can Med Assoc J 1981;124:1279-1295.
29. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988;49(3): 219-224.
30. Berizer DG. Medical consequences of alcohol addiction. In: Miller NS, ed. Comprehensive Handbook of Drug and Alcohol Addiction. New York: Marcel Dekker, 1991, 551-571.
31. Klatsky AL. The cardiovascular effects of alcohol. Alcohol Alcohol 1987;22(suppl 1):117-124.
32. Sellers EM, Kalant H. Alcohol intoxication and withdrawal. N Engl J Med 1976;294:757-762.
33. Goodwin DW, Hill SY. Chronic effects of alcohol and other psychoactive drugs on intellect, learning and memory. In: Rankin G, ed. Alcohol, Drugs, and Brain Damage. Toronto: Addiction Research Foundation, 1975:55-69.
34. Schuckit MA. Drug and Alcohol Abuse. New York, Plenum Press, 1989.
35. Geller A. Neurological effects of drug and alcohol addiction. In: Miller NS, ed. Comprehensive Handbook of Drug and Alcohol Addiction. New York: Marcel Dekker, 1991:599-621.
36. Ng SK, Hanser WA, Brust JC, Susser M. Alcohol consumption and withdrawal in new onset seizures. N EngI J Med 1988;319:666-673.
37. Helzer JE, Burnam A, McEvoy LT. Alcohol abuse and dependence. In Robins LN, Regier DA (eds): Psychiatric Disorders in America. New York: Free Press, 1991:81-115.
38. National Council on Alcoholism, Criteria Committee. Criteria for the diagnosis of alcoholism. Am J Psychiatry 1972; 129: 127-135.
39. Miller PM, Anton RF. Biochemical alcohol screening in primary health care. Addict Behav 2004;29(7):1427-1437.
40. Niemela O. Biomarkers in alcoholism. Clin Chim Acta 2007;377(1-2):39-49.
41. Harada S, Agarwal DP, Goedde HW. Biochemical and hema-tological markers of alcoholism. In: Goedde HW, Agarwal DP, eds. Alcoholism Biomedical and Genetic Aspects. New York: Pergamon, 1989:238-255.
42. Chan AWK. Biochemical markers for alcoholism. In: Miller NS, ed. Comprehensive Handbook of Drug and Alcohol Addiction. New York: Marcel Dekker, 1991:311-338
43. National Academy of Clinical Biochemistry, Laboratory Guidelines for Screening, Diagnosis and Monitoring of Hepatic Injury, 2000.
44. Anton RF, Lieber C, Tabakoff B. CDTect Study Group. Carbohydrate- deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002;26(8):1215-1222.
45. Rosman AS, Lieber CS. Biochemical markers of alcohol consumption. Alcohol Health Res World 1990;14: 210-218.
46. Sillanaukee P, Olsson U. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient trans-ferrin and gamma-glutamyltransferase. Clin Chem 2001;47(4): 681-685.
47. Chen J, Conigrave KM, Macaskill P, Whitfield JB, Irwig L. Behalf of the World Health Organization and the International Society for Biomedical Research on Alcoholism Collaborative Group. Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking. Alcohol Alcohol 2003;38(6):574-582.
48. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252(14):1905-1907.
49. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993;88(6):791-804.
50. Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med 2000;160(13):1977-1989.
51. Bradley KA, Bush KR, McDonell MB, Malone T, Fihn SD. Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. J Gen Intern Med 1998;13(6):379-388.
52. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158(16):1789-1795.
53. Goodwin DW, Crane JB, Guze SB. Felons who drink: An 8-year follow-up. Q J Stud Alcohol 1971;32:136-147.
54. Vaillant G. The Natural History of Alcoholism. Cambridge, MA: Harvard University Press, 1983.
55. Hyman MM. Alcoholics 15 years later. Ann NY Acad Sci 1976;273:613-623.
56. Helzer JE, Robins LN, Taylor JR, et al. The extent of long-term moderate drinking among alcoholics discharged from medical and psychiatric treatment facilities. N Engl J Med 1985;312:1678-1682.
57. Finney JW, Moos RH. The long-term course of treated alcoholism: 1. Mortality, relapse, and remission rates and comparisons with community controls. J Stud Alcohol 1991;52:44-54.
58. Ojesjo L. Long-term outcome in alcohol abuse and alcoholism among males in the Lundley general population, Sweden. Br J Addict 1981;76:391-400.
59. Jellinek EM. Phases of alcohol addiction. Q J Stud Alcohol 1952;13:673-684.
60. Trice HM, Wahl JR. A rank-order analysis of the symptoms of alcoholism. Q J Stud Alcohol 1958;19:636-648.
61. Park P, Whitehead PC. Developmental sequence and dimensions of alcoholism. Q J Stud Alcohol 1973;34:887-904.
62. Paredes A, Hood W, Seymour H, et al. Loss of control in alcoholism: An investigation of the hypothesis with experimental findings. Q J Stud Alcohol 1973;34:1146-1161.
63. Clark W. Loss of control, heavy drinking and drinking problems in a longitudinal study. J Stud Alcohol 1976;37:1256-1290.
64. Pattison EM, Sobell MB, Sobell LC. Emerging Concepts of Alcohol Dependence. New York: Springer, 1977.
65. Goodwin DW, Crane JB, Guze SB. Alcoholic "black-outs": A review and clinical study of 100 alcoholics. Am J Psychiatry 1969;126:191-198.
66. Lemere F. What happens to alcoholics? Am J Psychiatry 1953;109:674-676.
67. Bratfos O. The Course of Alcoholism: Drinking, Social Adjustment and Health. Oslo, Norway: Universitet Forlaget, 1974.
68. Lundquist GAR. Alcohol dependence. Acta Psychiatr Scand 1973;49:332-340.
69. Sundby P. Alcoholism and Mortality. Oslo, Norway: Univer-sitets Forlaget, 1967.
70. Myerson DJ, Mayer J. Origins, treatment and destiny of skid row alcoholic men. N Engl J Med 1966;275:419-424.
71. Nordstrom G, Berglund M. A prospective study of successful longterm adjustment in alcohol dependence: Social drinking versus abstinence. J Stud Alcohol 1987;48:95-103.
72. Taylor JR, Helzer JE. The natural history of alcoholism. In: Kissin B, Begleiter H eds. The Biology of Alcoholism, vol 6. New York: Plenum Press, 1983:17-65.
73. Pokorny AD, Kanas T, Overall J. Order of appearance of alcoholic symptoms. Alcohol Clin Exp Res 1981;5:216-220.
74. Fillmore KM. Relationship between specific drinking problems in early adulthood and middle age: An exploratory 20-year follow-up study. Q J Stud Alcohol 1975;6:882-907.
75. Pell S, D'Alonzo CA. A five-year mortality study of alcoholics. J Occup Med 1973;15:120-125.
76. Barr HL, Antes D, Ottenberg DJ, Rosen A. Mortality of treated alcoholics and drug addicts: The benefits of abstinence. J Stud Alcohol 1984;45:440-452.
77. Bullock KI, Reed RJ, Grant I. Reduced mortality in alcoholics who achieve long-term abstinence. JAMA 1992;267:668-672.
78. Smith EM, Cloninger CR, Bradford S. Predictors of mortality in alcoholic women: A prospective follow-up study. Alcohol Clin Exp Res 1983;7:237-243.
79. Glatt MM. An alcoholic unit in a mental hospital. Lancet 1959; 2:397-398.
80. Glatt MM. Drinking habits of English (middle-class) alcoholics. Acta Psychiatr Scand 1961;37:88-113.
81. Gomberg E. Alcoholism in women. In: Kissin B, Begleiter H, eds. Biology of Alcoholism, vol 4. New York: Plenum Press, 1976:117-166.
82. Ashley MJ, Olin JW, le Reiche WM, et al. Morbidity in alcoholics. Arch Intern Med 1977;137:883-887.
83. Blume S. Women, alcohol, and drugs. In: Miller NS, ed. Comprehensive Handbook of Drug and Alcohol Addiction. New York: Marcel Dekker, 1991:147-177.
84. Liban C, Smart RG. Generational and other differences between males and females in problem drinking and its treatment. Drug Alcohol Depend 1980;5:207-221.
85. Wilsnack SC. Alcohol abuse and alcoholism in women. In: Pattison EM, Katiftnan E, eds. Encyclopedia Handbook of Alcoholism. New York: Gardner Press, 1982:718-735.
86. Winokur G, Clayton P. Family history studies II. Sex differences and alcoholism in primary affective illness. Br J Psychiatry 1967;113:973-979.
87. Ludwig AM. On and off the wagon: Reasons for drinking and abstaining by alcoholics. Q J Stud Alcohol 1972;33:91-96.
88. Sobell LC, Sobell MB, Toneatto T, Leo GI. What triggers the resolution of alcohol problems without treatment. Alcohol Clin Exp Res 1993;17(2):217-224.
89. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001;3(4):181-188.
90. Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005;80(1):105-116.
91. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987;236:410-416.
92. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B. Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 1992;49(8):599-608.
93. Lesch OM, Kefer J, Lentner S, Mader R, Marx B, Musalek M, Nimmerrichter A, Preinsberger H, Puchinger H, Rustembe-govic A, et al. Diagnosis of chronic alcoholism-classificatory problems. Psychopathology 1990;23(2):88-96.
94. Babor TF, Caetano R. Subtypes of substance dependence and abuse: Implications for diagnostic classification and empirical research. Addiction 2006;101(Suppl 1):104-110.
95. Burton R. The Anatomy of Melancholy, vol 1. London: William Tegg, 1906.
96. Goodwin DW, Schulsinger F, Hermansen L, et al. Alcohol problems in adoptees raised apart from alcoholic biological parents. Arch Gen Psychiatry 1973;28:238-243.
97. Bohman M. Genetic aspects of alcoholism and criminality. Arch Gen Psychiatry 1978; 35:269-276.
98. Cadoret RJ, Cain CA, Grove WM. Development of alcoholism in adoptees raised apart from alcoholic biologic relatives. Arch Gen Psychiatry 1979;37:561-563.
99. Bohman M, Cloninger R, Sigvardsson S, von Knorring AL. The genetics of alcoholisms and related disorders. J Psychiatr Res 1987;21(4):447-452.
100. Prescott CA, Kendler KS. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999;156(1): 34-40.
101. Kendler KS, Neale MC, Heath AC, Kessler RC, Eaves LJ. A population-based twin study of alcoholism in women. JAMA 1992;268(14):1877-1882.
102. Thomasson HR, Edenberg HJ, Crabb DW, Mai XL, Jerome RE, Li TK, Wang SP, Lin YT, Lu RB, Yin SJ. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet 1991;48(4):677-681.
103. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004;63(1):49-63.
104. Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M. Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995;152:1219-1221.
105. Edenberg HJ, Foroud T. The genetics of alcoholism: identifying specific genes through family studies. Addict Biol 2006;11(3-4):386-396.
106. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003;116(1):103-125.
107. Schuckit MA. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 1994;151(2): 184-189.
108. Kamarajan C, Porjesz B, Jones K, Chorlian D, Padmanab-hapillai A, Rangaswamy M, Stimus A, Begleiter H. Event-related oscillations in offspring of alcoholics: neurocogni-tive disinhibition as a risk for alcoholism. Biol Psychiatry 2006;59(7):625-634.
109. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005;29(1):8-16.
110. Begleiter H, Porjesz B, Bihari B, Kissin B. Event-related brain potentials in boys at risk for alcoholism. Science 1984;225(4669):1493-1496.
111. Jones KA, Porjesz B, Almasy L, Bierut L, Dick D, Goate A, Hinrichs A, Rice JP, Wang JC, Bauer LO, Crowe R, Foroud T, Hesselbrock V, Kuperman S, Nurnberger J Jr, O'Connor SJ, Rohrbaugh J, Schuckit MA, Tischfield J, Eden-berg HJ, Begleiter H. A cholinergic receptor gene (CHRM2) affects event-related oscillations. Behav Genet 2006;36(5): 627-369.
112. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005;162(8):1403-1413.
113. Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 2003;27(2):232-243.
114. Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clin Psychol Rev 2002;22(1):27-77.
115. Grube JW, Stewart K. Preventing impaired driving using alcohol policy. Traffic Inj Prev 2004;5(3):199-207.
116. Victor M, Adams RD. The effects of alcohol on the nervous system. In: Merritt H, Hare C, eds. Metabolic and Toxic Diseases of the Nervous System. Baltimore: Williams & Wilkins, 1953.
117. Ferguson JA, Suelzer CJ, Eckert GJ, Zhou XH, Dittus RS. Risk factors for delirium tremens development. J Gen Intern Med 1996;11(7):410-414.
118. Fiellin DA, O'Connor PG, Holmboe ES, Horwitz RI. Risk for delirium tremens in patients with alcohol withdrawal syndrome. Subst Abus 2002;23(2):83-94.
119. Foy A, March S, Drinkwater V. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res 1988;12(3):360-364.
120. Foy A, Kay J, Taylor A. The course of alcohol withdrawal in a general hospital. QJM 1997;90(4):253-261.
121. Palmstierna T. A model for predicting alcohol withdrawal delirium. Psychiatr Serv 2001;52(6):820-823.
122. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989;84(11):1353-1357.
123. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 1997;278(2):144-151.
124. Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J; Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004;164(13):1405-1412.
125. Ogata M, Mendelson J, Mello N. Electrolytes and osmo-lality in alcoholics during experimentally induced intoxication. Psychosom Med 1968;30:463-488.
126. O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet 1996;347(8996):237-240.
127. Sobell MB, Sobell LC. Controlled drinking after 25 years: How important was the great debate? Addiction 1995;90: 1149-1153.
128. Fleming MF, Barry KL, Manwell LB, Johnson K, London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA 1997;277(13):1039-1045.
129. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol 1983;51(3):390-395.
130. Miller WR, Wilbourne PL. Mesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002;97(3):265-277.
131. Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Brief physician advice for problem drinkers: Long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res 2002;26(1):36-43.
132. Project MATCH Writing Group. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997;58(1):7-29.
133. Project MATCH Writing Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res 1998;22(6): 1300-1311.
134. Wright C, Moore RD. Disulfiram treatment of alcoholism. Ann Intern Med 1989; 111:943-944.
135. Chick J. Safety issues concerning the use of disul-firam in treating alcohol dependence. Drug Saf 1999;20(5): 427-435.
136. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA 1986;256(11): 1449-1455.
137. Chick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehta B, Ritson B, Ropner R, Torley D. Disulfiram treatment of alcoholism. Br J Psychiatry 1992;161:84-89.
138. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence: A review of the evidence. JAMA 1999;281(14):1318-1325.
139. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 1992;49(11):881-887.
140. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49(11):876-880.
141. Bouza C, Angeles M, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review. Addiction 2004;99(7): 811-828.
142. Kranzler HR, Van Kirk J. Efficacy of naltrexone and acam-prosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 2001;9:1335-1341.
143. Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: A meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2005;8(2):267-280.
144. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry 1995;152:613-615.
145. De Witte P, Littleton J, Parot P, Koob G. Neuroprotective and abstinence-promoting effects of acamprosate: Elucidating the mechanism of action. CNS Drugs 2005;19(6):517-537.
146. Mason BJ, Goodman AM, Chabac S, Lehert P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: The role of patient motivation. J Psychiatr Res 2006;40:383-393.
147. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA 2006;295:2003-2017.
148. Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Petti-nati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 2005;293:1617-1625.
149. Kranzler HR, Wesson DR, Billot L; Drug Abuse Sciences Naltrexone Depot Study Group. Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res 2004;28: 1051-1059.
150. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2003;60:92-99.
151. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharma-cology 2003;28:1546-1552.
152. Gastfriend DR, Garbutt JC, Pettinati H, Forman R. Reduction in heavy drinking as a treatment outcome in alcohol dependence. J Subst Abuse Treat 2007;33:71-80.
153. Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol 2001;62:211-220.
154. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005;352:596-607.
155. Sass H, Soyka M, Mann K, Zieglgansberger W. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996;53:673-680.